ENTRY       D09316                      Drug
NAME        Pegloticase (USAN/INN);
            Krystexxa (TN)
PRODUCT     KRYSTEXXA (Horizon Therapeutics USA)
FORMULA     C1549H2430N408O448S8
EXACT_MASS  34171.7673
MOL_WEIGHT  34192.8533
SOURCE      Sus scrofa [TAX:9823]
REMARK      ATC code: M04AX02
            Product: D09316<US>
EFFICACY    Gout suppressant
  DISEASE   Chronic gout [DS:H01532]
COMMENT     Pegloticase is PEG-recombinant uricase [EC:1.7.3.3]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M04 ANTIGOUT PREPARATIONS
               M04A ANTIGOUT PREPARATIONS
                M04AX Other antigout preparations
                 M04AX02 Pegloticase
                  D09316  Pegloticase (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antigout Agents
              Pegloticase
               D09316  Pegloticase (USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09316
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09316
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D09316
DBLINKS     CAS: 885051-90-1
            PubChem: 96025996
///
